The Sequence of Chemotherapy and Toripalimab Might Influence the Efficacy of Neoadjuvant Chemoimmunotherapy in Locally Advanced Esophageal Squamous Cell Cancer—A Phase II StudyWenqun Xing, Quanli Gao, Lingdi Zhao et al.|Frontiers in Immunology|2021Cited by 73
The sequence of chemotherapy and anti-PD-1 antibody influence the efficacy of neoadjuvant immunochemotherapy in locally advanced esophageal squamous cell cancer: A phase II study.Lingdi Zhao, Quanli Gao, Wenqun Xing et al.|Journal of Clinical Oncology|2021Cited by 15
High Complete Response Rate in Patients With Metastatic Renal Cell Carcinoma Receiving Autologous Cytokine-Induced Killer Cell Therapy Plus Anti-Programmed Death-1 Agent: A Single-Center StudyLingdi Zhao, Quanli Gao, Yonghao Yang et al.|Frontiers in Immunology|2022Cited by 15
Factors Influencing the Efficacy of Anti-PD-1 Therapy in Chinese Patients with Advanced MelanomaLingdi Zhao, Quanli Gao, Yonghao Yang et al.|Journal of Oncology|2019Cited by 12
Combination of Sorafenib and Cytokine-Induced Killer Cells in Metastatic Renal Cell Carcinoma: A Potential RegimenYonghao Yang, Quanli Gao, Hongwei Lin et al.|Immunotherapy|2017Cited by 9